New York – May 10, 2023 - Research Nester’s recent market research reporton “Sexually Transmitted Disease Testing  Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview in terms of market segmentation by disease, location, device, and by region.

Growing Cases of Sexually Transmitted Disease (STD) to Promote Global Market Share of Sexually Transmitted Disease Testing

The global sexually transmitted disease testing market is estimated to grow majorly on account of the increasing prevalence of sexually transmitted diseases (STDs). The prevalence of STDs is increasing owing to people's active sexual lives, many partner options, and lack of use of contraceptives. Furthermore, the need for STD diagnostics is predicted to increase as a result of the rising prevalence and frequency of sexually transmitted diseases around the world, which is driving sexually transmitted disease testing market growth. As per The World Health Organisation, more than 1.0 million sexually transmitted infections occur worldwide, the majority of which are asymptomatic. Additionally, it is noted that each year, about 374 million new cases of one of the four sexually transmitted diseases gonorrhea, chlamydia, trichomoniasis, and syphilis occur. 

The global sexually transmitted disease testing market is expected to increase significantly as the global population of young adults grows. In general, it is found that young individuals are more sexually and socially interested. They often engage in more sexual activity with more partners as a result of their expanded minds, making them more vulnerable to STDs. Moreover, as people go from adolescence to young adulthood, casual sexual activity participation becomes even more prevalent. In addition, social networking is becoming more and more ingrained in the sexual customs of young people. Throughout the forecast, this tendency is anticipated to fuel sexually transmitted disease testing market expansion. According to statistics, each year one in 20 young people worldwide contract STDs, and the rate is reported to be higher for people between the ages of 20 and 24.

Some of the major growth factors and challenges that are associated with the growth of the global sexually transmitted disease testing market are:

Growth Drivers:

• Surge in Rape Cases and Sexual Harassment Globally
• Growing Insurance Policy for STD Testing and Treatment

Challenges:

The persistence of social stigma with sexually transmitted diseases, and the exorbitant cost of systems needed for STD detection are some of the major factors anticipated to hamper the sexually transmitted disease testing market size of sexually transmitted disease testing. For instance, a sizeable percentage of people are unwilling to discuss sex or undergo STD testing and treatment, which may be owing to a lack of sexual education, ignorance, or social anxiety. According to data, it is believed that many STDs are socially stigmatized. In other words, people are stigmatized or judged for having STDs. Despite the continued social stigma associated with STDs, it has been established that sexually transmitted diseases are the frequent disease. Further, people still have a mistaken perception of sex or sex-related difficulties despite the rise in the educated population. Thus, it is anticipated that the developing social stigma will impede market expansion.

Access our detailed report on Sexually Transmitted Disease Testing Market Analysis by Disease (Human Immunodeficiency Virus, Herpes Simplex Virus, Human Papillomavirus, Chlamydia, Syphilis, Gonorrhea, Cancroid); Location (Laboratory, Point of Care); Device (Laboratory Devices, Point of Care Devices) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033 @: https://www.researchnester.com/reports/sexually-transmitted-disease-testing-market/4461

By disease, the sexually transmitted disease testing market is segmented into human immunodeficiency virus, herpes simplex virus, human papillomavirus, chlamydia, syphilis, gonorrhea, cancroid, and others. The chlamydia segment is to garner the highest revenue by the end of 2035 by growing at a significant CAGR over the forecast period. The reason behind the growth of the segment is attributed to higher rates of chlamydia in young people from unprotected intercourse and adults from engaging with multiple partners. Besides this, there has been growing awareness regarding the treatment for chlamydia, which may boost the segment’s growth in the sexually transmitted disease testing market. The World Health Organisation (WHO) estimates that there will be around 129 million cases of chlamydia worldwide in 2020. In addition, a total of 1,808,703 chlamydia cases were reported to the Centers for Disease Control and Prevention in 2019.

By region, the Asia Pacific sexually transmitted disease testing market is to generate the highest revenue by the end of 2035. This growth is anticipated by the higher rate of crimes related to sexual harassment leading to growing chances of acquiring sexually transmitted diseases and a lack of sex education in the region. The growing chances of acquiring STDs in the area may increase the demand for sexually transmitted disease testing as it is a part of medical care and oftentimes it is recommended by healthcare. In India, there have been reported 86 rapes per day and 50 or so sexual assaults against women every hour in 2021. Moreover, there are between 250,000 and 2 million sex workers in Thailand. Further, more than 20,000 STD-related deaths and about 20,000 AIDS-related deaths occurred in China in 2021.

This report also provides the existing competitive scenario of some of the key players of the global drug delivery systems market which includes company profiling of bioMerieux, Becton Dickinson and Company, Quest Diagnostics, Thermo Fisher Scientific, Hologic Inc., Orasure Technologies, Inc., S&P Global, DiaSorin Molecular LLC.